Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS)

Sleep Medicine Reviews

Volumn 7, Issue 1, 2003, Pages 81-99

  Engleman, Heather M ^a,c   Wild, Matt R ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cognitive behavioural therapy; Patient compliance; Positive pressure ventilation; Sleep apnoea syndromes

Indexed keywords

COGNITION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; HUMIDIFIER; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP APNEA SYNDROME; SOCIAL PSYCHOLOGY;

EID: 0037317742     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1053/smrv.2001.0197     Document Type: Review

References (59)

1. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnoea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 1108-1114.
2. Krieger J. Long-term compliance with CPAP therapy in obstructive sleep apnoea patients and in snorers. Sleep 1996; 19: S 136-S143.
3. Krieger J. Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnoea patients and nonapneic snorers. Sleep 1992; 15: S42-S46.
4. Lacassagne L, Didier A, Doussau S, Murris-Espin M, Birot P, Charlet JP, Thach KS, Tiberge M et al. Results of 248 patients with sleep apnoea syndrome treated by continuous positive airway pressure ventilation between 1990 and 1995: a study of compliance and outcome of the apnoea-hypopnea index. Revue des Maladies Respiratoires 2000; 17: 467-474.
5. Pieters T, Collard P, Aubert G, Dury M, Delguste P, Rodenstein DO. Acceptance and long-term compliance wih nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J 1996; 9: 939-944.
6. Waldhorn RE, Herrick TW, Nguyen MC, O'Donnell AE, Sodero J, Potolicchio SJ. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnoea. Chest 1990; 97: 33-38.
7. Rauscher H, Popp W, Wanke T, Zwick H. Acceptance of CPAP therapy for sleep apnoea. Chest 1991; 100: 1019-1023.
8. Meurice J-C, Dore P, Paquereau J, Neau J-P, Ingrand P, Chavagnat J-J, Patte F. Predictive factors of longterm compliance with nasal continuous positive airway pressure treatment in sleep apnoea syndrome. Chest 1994; 105: 429-433.
9. Fleury B, Rakatonanahary D, Tehindrazanarivelo AD, Hausser-Hauw C, Lebeau B. Long-term compliance to continuous positive airway pressure therapy (nCPAP) set up during a split-night polysomnography. Sleep 1994; 17: 512-515.
10. Edinger JD, Carwile S, Miller P, Mayti C. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnoea. Perceptual and Motor Skills 1994; 78: 1116-1118.
11. Kingshott RN, Vennelle M, Hoy CJ, Engleman HM, Deary IJ, Douglas NJ. Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med 2000; 161: 866-871.
12. Pépin JL, Krieger J, Rodenstein D, Cornette A, Sforza E, Delguste P, Deschaux C, Grillier V, Levy P. Effective compliance during the first 3 months of continuous positive airway pressure; a European prospective study of 121 patients. Am J Respir Crit Care Med 1999; 160: 1124-1129.
13. Reeves-Hoché MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149: 149-154.
14. Noseda A, Jann E, Hoffman G, Linkowski P, Kerkhofs M. Compliance with nasal continuous positive airway pressure assessed with a pressure monitor: pattern of use and influence of sleep habits. Respir Med 2000; 94: 76-81.
15. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnoea. Am Rev Respir Dis 1993; 147: 887-895.
16. Engleman HM, Martin SE, Douglas NJ. Compliance with continuous positive airway pressure therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax 1994; 49: 263-266.
17. Weaver TE, Kribbs NB, Pack AI, Kline LR, Chugh DK, Maislin G, Smith PL, Schwartz AR et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997; 20: 278-283.
18. Bennett LS, Langford BA, Stradling JR, Davies RJ. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnoea. Am J Respir Crit Care Med 1998; 158: 778-786.
19. Meslier N, LeBrun T, Grillier-Lanoir, Rolland N, Henderick C, Sailly J-C, Racineux J-L. A French survey of 3225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 1998; 12: 185-192.
20. Janson C, Noges E, Svedberg-Randt S, Lindberg E. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment? Respir Med 2000; 94: 145-149.
21. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy. Chest 1996; 109: 1470-1476.
22. Rolfe I, Olson LG, Saunders NA. Long-term acceptance of continuous positive airway pressure in obstructive sleep apnoea. Am Rev Respir Dis 1991; 144: 1130-1133.
23. Nino-Murcia G, McCann CC, Bliwise DL, Guille-minault C, Dement WC. Compliance and side effects in sleep apnoea patients treated with nasal continuous positive airway pressure. West J Med 1989; 150: 165-169.
24. Hoffstein V, Viner S, Mateika, Conway J. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure; patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992; 145: 841-845.
25. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnoea. Chest 1993; 103: 1675-1680.
26. Pépin JL, Leger P, Veale D, Langevin B, Robert D, Lévy R Side effects of nasal continuous positive airway pressure in sleep apnoea syndrome. Chest 1995; 107: 375-381.
27. Kalan A, Kenyon GS, Seemungal TA, Wedzicha JA. Adverse effects of nasal continuous positive airway pressure therapy in sleep apnoea syndrome. J Laryngol Otal 1999; 113: 888-892.
28. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnoea patients. Chest 1999: 116: 403-408.
29. Wiest GH, Lehnert G, Bruck WM, Meyer M, Hahn EG, Ficker JH, A heated humidifier reduces upper airway dryness during continuous positive airway pressure therapy. Respir Med 1999; 93: 21-26.
30. Reeves-Hoché MK, Meck R, Zwillich CW. Continuous versus bilevel positive airway pressure for obstructive sleep apnoea. Am J Respir Crit Care Med 1995; 151: 443-449.
31. Konermann M, Sanner BM, Vyleta M, Laschewski F, Groetz J, Sturm A, Zidek W. Use of conventional and self-adjusting nasal continuous positive airway pressure for treatment of severe obstructive sleep apnoea syndrome: a comparative study. Chest 1998; 113: 714-718.
32. Meurice J-C, Marc I, Sériès F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnoea/hypopnea syndrome. Am J Respir Crit Care Med 1996; 153: 794-798.
33. Fletcher EC and Luckett RA. The effect of positive reinforcement on hourly compliance in nasal continuous positive airway pressure users with obstructive sleep apnoea. Am Rev Respir Dis 1991; 143: 936-941.
34. Hui DS, Chan JK, Choy DK, Ko FW, Li TS, Leung RC, Lai CK. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest 2000; 117: 1410-1416.
35. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnoea/hypopnea syndrome? Am J Respir Crit Care Med 1999; 159: 1096-100.
36. Chervin RD, Theut S, Bassetti C, Aldrich MS. Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997; 20: 284-289.
37. Likar LL, Panciera TM, Erickson AD, Rounds S. Group education sessions and compliance with nasal CPAP therapy. Chest 1997; 111: 1273-1277.
38. Wallston, KA Hocus-pocus the focus isn't strictly on the locus: Rotter's social learning theory modified for health. Cognitive Theory and Research 1992; 16: 183-199.
39. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of CPAP for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461-467.
40. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnea syndrome. Thorax 1997; 52: 114-119.
41. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenburg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998; 157: 858-865.
42. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed, Erlbaum, New Jersey, 1988.
43. Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sullivan CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154: 182-186.
44. Boudewyns A, Grillier-Lanoir V, Willemson MJ, De Cock WA, Van de Heyning PH, De Backer WA. Two months follow-up of auto-CPAP treatment in patients with obstructive sleep apnoea. Thorax 1999; 54: 147-149.
45. Ballester E, Badia JR Hernández L, Carrasco E, De Pablo J, Fornas C, Rodriguez-Roisin R, Montserrat JM. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 495-501.
46. Bosely CM, Fosbury JA, Cochrane GM. Psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995; 8: 899-904.
47. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelburg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997; 35: 1164-1170.
48. Rogers AE, Aldrich MS, Berrios AM, Rosenburg RS. Compliance with stimulant medications in narcolepsy. Sleep 1997; 20: 28-33.
49. Kavanagh, DJ, Gooley, S. Wilson, PH. Prediction of adherence in diabetes. Journal of Behavioural Medicine 1993; 16: 509-522.
50. Conner, M. Norman, P (eds). Predicting health behaviour. Open University Press, Buckingham 1995.
51. Blackburn I-M Davidson K. Cognitive therapy for depression and anxiety. Blackwell, Cambridge 1990.
52. Hawton K, Salkovskis PM, Kirk J, Clark DM. Cognitive behaviour therapy for psychiatric problems. Oxford University Press, New York 1989.
53. White CA. Cognitive behaviour therapy for chronic medical problems: a guide to assessment and treatment in practice. Wiley, Chichester 2001.
54. McFadyen T, Engleman HM, Espie C, Douglas NJ. Psychosocial function before and after CPAP treatment. Eur Respir J 2001, in press.
55. Wild M, Espie C, Douglas NJ, Engleman HM. Psychological and clinical predictors of adherence to continuous positive airway pressure therapy for obstructive sleep apnoea: a prospective study. social determinants of adherence to CPAP therapy. Psychologist 2001, suppl; in press.
56. Engleman HM, McDonald J, Graham D, Lello G, Douglas NJ. Randomized controlled crossover trial of CPAP vs. MRS therapy for the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001; 163 (5 Suppl): A837.
57. Weaver T, Maislin G, Schwab R, Cantor C, Younger J, Dinges D, Pack A. Perception of OSA risks and benefit and volition to use CPAP. Am J Respir Crit Care Med 2001; 163(5 Suppl): A838.
58. Lau RR, Hartman KA, Ware JE. Health as value: methodological and theoretical considerations. Health Psychology 1986; 5: 25-42.
59. Jokic R, Klimaszewski A, Sridhar G, Fitzpatrick MF. Continuous positive airway pressure requirement during the first month of treatment in patients with severe obstructive sleep apnea. Chest 1998; 114: 1061-1069.